July 13, 2026

Teva Pharmaceutical Industries (TEVA): Exploring a 24% Upside Potential Amid Strong Buy Ratings

For investors keeping a keen eye on the healthcare sector, Teva Pharmaceutical Industries Limited (NYSE: TEVA) presents an intriguing opportunity. With a market capitalization of $38.37 billion, Teva stands as..

Penumbra, Inc. (PEN) Stock Analysis: Exploring Growth Potential and Analyst Ratings in the Medical Device Sector

Penumbra, Inc. (NYSE: PEN), a prominent player in the healthcare sector, is capturing investors’ attention with its innovative medical devices and solid market positioning. Incorporated in 2004 and headquartered in..

ICON plc (ICLR) Stock Analysis: A Healthcare Giant with 7.81% Potential Upside

ICON plc (NASDAQ: ICLR), a leading player in the Healthcare sector specializing in Diagnostics & Research, is gaining attention from investors with its potential upside of 7.81%. Headquartered in Dublin,..

TransMedics Group, Inc. (TMDX): A Medical Device Innovator with a 63% Potential Upside

TransMedics Group, Inc. (NASDAQ: TMDX), a trailblazer in the healthcare sector, is reshaping the landscape of organ transplant therapy. With a market capitalization of $2.46 billion, this United States-based company..

Cardinal Health, Inc. (CAH) Stock Analysis: Navigating Growth Amidst a Robust Healthcare Sector

Cardinal Health, Inc. (NYSE: CAH), a prominent player in the healthcare sector, has consistently demonstrated its capacity to innovate and adapt within the medical distribution industry. With a market capitalization..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating a Mixed Outlook with Key Insights for Investors

Molina Healthcare Inc (NYSE: MOH) stands out in the healthcare plans industry as a major player with a significant market cap of $12.16 billion. The company specializes in providing managed..

Cencora, Inc. (COR) Stock Analysis: Strong Buy Ratings and Growth Potential in the Healthcare Sector

Cencora, Inc. (COR), formerly known as AmerisourceBergen Corporation, represents a significant player in the healthcare industry, particularly in medical distribution. With a market cap of $59.04 billion, Cencora has established..

Labcorp Holdings Inc. (LH) Stock Analysis: A 12.35% Potential Upside Beckons Investors

Labcorp Holdings Inc. (NYSE: LH), a stalwart in the healthcare sector, operates at the intersection of diagnostics and research. With a robust market capitalization of $22.7 billion, this United States-based..

BridgeBio Pharma (BBIO) Stock Analysis: Uncovering a 21.37% Potential Upside in Biotech

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is making waves in the biotech sector with its robust pipeline dedicated to genetic disease treatments. With a market capitalization of $16.82 billion, this Palo..

The Ensign Group, Inc. (ENSG) Stock Analysis: Eyeing a 30.73% Potential Upside

The Ensign Group, Inc. (NASDAQ: ENSG) stands as a formidable player in the healthcare sector, specializing in medical care facilities across the United States. With a market capitalization of $9.85..

Vertex Pharmaceuticals (VRTX) Stock Analysis: A Biotech Giant with a 14% Upside Potential

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a formidable player in the biotechnology sector, boasting a robust market capitalization of $123.19 billion. Known for its transformative therapies targeting serious diseases,..

Align Technology, Inc. (ALGN)

⚠️ No article content returned.

..

Glaukos Corporation (GKOS) Stock Analysis: A Healthcare Innovator with a 5.57% Upside Potential

Glaukos Corporation (NYSE: GKOS), a prominent player in the healthcare sector, specifically within the medical devices industry, has been capturing investor attention with its innovative products and promising financial outlook...

Ionis Pharmaceuticals (IONS): Analyst Consensus Reveals 60% Upside Potential for This Biotech Innovator

For investors with an eye on the biotechnology sector, Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) presents a compelling opportunity. As a commercial-stage biotechnology company headquartered in Carlsbad, California, Ionis is at..

Guardant Health, Inc. (GH) Stock Analysis: Navigating High Growth in the Precision Oncology Market

Guardant Health, Inc. (NASDAQ: GH), a leader in precision oncology, has been capturing investor attention with its innovative solutions in cancer diagnostics and research. Headquartered in Palo Alto, California, the..

AbbVie Inc. (ABBV) Stock Analysis: Exploring a Market Leader’s Potential Amidst Healthcare Innovation

AbbVie Inc. (NYSE: ABBV), a titan in the healthcare sector, stands as a compelling consideration for investors seeking exposure to the drug manufacturing industry. With a robust market capitalization of..

Globus Medical, Inc. (GMED) Stock Analysis: Exploring a 37.52% Potential Upside in the Medical Devices Sector

As the healthcare sector continues its dynamic expansion, Globus Medical, Inc. (NYSE: GMED) stands out in the medical devices industry with a compelling investment case. With a market capitalization of..

argenx SE (ARGX) Stock Analysis: A Biotech Powerhouse with 19.64% Upside Potential

argenx SE (ARGX), a prominent player in the biotechnology sector, has captured the attention of investors with its promising pipeline and impressive market performance. Based in the Netherlands, argenx is..

Fresenius Medical Care AG (FMS) Stock Analysis: Insights into a 3.63% Dividend Yield and Growth Potential

Investors interested in the healthcare sector, particularly in medical care facilities, should pay close attention to Fresenius Medical Care AG (FMS). As a global leader in dialysis services and products,..

Qiagen N.V. (QGEN) Stock Analysis: Healthcare Innovator with a Promising 7.11% Upside

Qiagen N.V. (NYSE: QGEN), a prominent player in the healthcare sector, particularly within the diagnostics and research industry, is making headlines with its innovative approaches to transforming biological samples into..

Search

Funds

July 13, 2026

Search

Funds

July 13, 2026

FTSE 100

Funds